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Previous studies have mostly shown positive effects of cannabis use on cognition in
patients with schizophrenia, which could reflect lower neurocognitive vulnerability. There
are however no studies comparing whether such cognitive differences have neuronal corre-
lates. Thus, the aim of the present study was to compare whether patients with previous
cannabis use differ in brain activation from patients who has never used cannabis. The
patients groups were compared on the ability to up-regulate an effort mode network during
a cognitive task and down-regulate activation in the same network during a task-absent con-
dition.Task-present and task-absent brain activation was measured by functional magnetic
resonance neuroimaging (fMRI). Twenty-six patients with a DSM-IV and ICD-10 diagno-
sis of schizophrenia were grouped into a previous cannabis user group and a no-cannabis
group. An auditory dichotic listening task with instructions of attention focus on either
the right or left ear stimulus was used to tap verbal processing, attention, and cognitive
control, calculated as an aggregate score. When comparing the two groups, there were
remaining activations in the task-present condition for the cannabis group, not seen in the
no-cannabis group, while there was remaining activation in the task-absent condition for
the no-cannabis group, not seen in the cannabis group. Thus, the patients with previous
cannabis use showed increased activation in an effort mode network and decreased acti-
vation in the default mode network as compared to the no-cannabis group. It is concluded
that the present study show some differences in brain activation to a cognitively challenging
task between previous cannabis and no-cannabis schizophrenia patients.
Keywords: schizophrenia, fMRI, cannabis, dichotic listening, default mode network, effort mode network, brain
activation, cognitive control
INTRODUCTION
It has been shown that cannabis use is more widespread in patients
with schizophrenia than in the healthy population (Regier et al.,
1990; Arseneault et al., 2004; Barnes et al., 2006). Possibly, cannabis
is a risk factor for schizophrenia (Andreasson et al., 1987; Zam-
mit et al., 2002; Arseneault et al., 2004; Moore et al., 2007),
mediated by the effect of the main psychoactive ingredient, Delta9-
tetrahydrocannabinol (THC) on the endogenous cannabinoid and
dopamine systems (D’Souza et al., 2005; Solowij and Michie, 2007;
Bossong and Niesink, 2010). Paradoxically, most neurocognitive
studies on schizophrenia have shown cannabis use to be a marker
of superior performance on neuropsychological tests. A systematic
literature review revealed better cognitive functioning in cannabis-
using compared to non-cannabis-using patients in a majority of
the reviewed 23 studies (Løberg and Hugdahl, 2009). This pat-
tern has been replicated by later studies (DeRosse et al., 2010;
Rodriguez-Sanchez et al., 2010), also including two meta-analyses
(Rabin et al., 2011; Yucel et al., 2012). It is of importance, however,
to differentiate between the consequences of ongoing cannabis use
and short-term intoxication effects versus the effects of previous
cannabis use as pathway to psychosis (Løberg and Hugdahl, 2009).
Recently, a large cross-sectional study compared the short-term
effect of cannabis and the effect of life-time cannabis use in 956
patients, and concluded that there was a short- time negative effect
on cognition and in contrast a positive long-term effect of life-
time use (Meijer et al., 2012). The authors suggested that the
life-time cannabis-using group formed a subgroup with a different
cognitive profile.
It has been proposed that better cognition reflects lower cog-
nitive vulnerability in schizophrenia patients with a history of
cannabis use (Løberg and Hugdahl, 2009). In such a model,
deficient cognition is a vulnerability marker, indicating neurode-
velopmentally based brain dysfunctions. In the typical patient
with no drug use, such brain dysfunctions render individuals
susceptible to psychosis. Cannabis use characterizes a subgroup
of schizophrenia patients with less cognitive deficits. For these
patients, cannabis use disturbs the functional integrity of the
brain creating a psychotic breakdown (Løberg and Hugdahl,
2009). Within a stress-vulnerability framework (Zubin and Spring,
1977; Insel, 2010), the tendency to develop schizophrenia is a
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function of vulnerability× stress. When cannabis is entered into
the equation as a stress factor, the importance of a high vul-
nerability load is decreased. More cannabis/stress× less vulner-
ability/neurocognitive deficits generates a tendency to develop
schizophrenia that is similar to less cannabis/stress× high vul-
nerability/neurocognitive deficits. Cognition is not an optimal
vulnerability marker, however, and neuropsychological test per-
formance is also confounded by motivational, and behavioral
variables, and is at best an indirect measure of brain functioning
that may vary with fluctuating psychosis symptoms and treatment
(Johnsen et al., 2011). It would therefore be of interest to inves-
tigate if the observed cognitive differences between cannabis and
no-cannabis schizophrenia patients also would be revealed in a
difference in brain activation between these sub-groups.
We therefore conducted a functional magnetic resonance imag-
ing (fMRI) study on a group of schizophrenia patients with
previous use of cannabis compared with a group of patients with-
out such experience. Of the few previous brain-imaging studies
conducted on cannabis use and schizophrenia, firm conclusions
cannot be drawn, and even evidence of adverse effects of cannabis
on the brain in healthy individuals is inconclusive (Block et al.,
2000; Jager et al., 2006; DeLisi, 2008; Martin-Santos et al., 2010).
Most functional brain-imaging studies on cannabis and schiz-
ophrenia have focused on the immediate and acute effects of
cannabis, not relevant for the present study. One fMRI study,
however, found that socio-emotional processing was less impaired
in patients with a dual diagnosis (mainly cannabis users) than
schizophrenia alone (Potvin et al., 2007). Studies comparing schiz-
ophrenia patients with and without cannabis use by means of
structural MRI and diffusion tensor imaging (DTI) have shown
more normalized (Dekker et al., 2010), more anomalous (Szeszko
et al., 2007; Bangalore et al., 2008; Rais et al., 2008; Ashtari et al.,
2011; Ho et al., 2011; James et al., 2011; Solowij et al., 2011),
and equivalent (Block et al., 2000; Cahn et al., 2004; Wobrock
et al., 2009; Cohen et al., 2012) brain anatomy in the cannabis
group, thus making firm conclusions difficult also when it comes
to structural imaging.
Possibly, both the severity and recency of cannabis use influ-
ence these results, in addition to interactions with genetic (Ho
et al., 2011) and environmental risk factors (Habets et al., 2008).
The inconsistency of results may also be attributed to different
definitions of cannabis use (current, life-time, or previous use, or
a cannabis use disorder). To examine the effects of cannabis on
brain functioning within a vulnerability framework, the effects of
cannabis use before the development of psychosis is important
(Løberg and Hugdahl, 2009). For this reason, only patients with
previous cannabis use were included in the present study. In addi-
tion, this would rule out potential confounding effects of cannabis
intoxication or recent cannabis use on brain activation, which have
been shown in some studies (Bhattacharyya et al., 2012; Bossong
et al., 2012; Skosnik et al., 2012).
Thus, we used an fMRI paradigm comparing activation during
alternating cognitive task-present and task-absent conditions. We
compared activation in two large-scale cortical networks during
these conditions, defined as an effort mode and a default mode
(cf. Raichle et al., 2001) network. For the task-present condition a
dichotic auditory perception task with attention instructions was
chosen (Hugdahl and Andersson, 1986; Løberg et al., 1999). This
task has the advantage of simultaneously tapping several cogni-
tive functions that are central to neurocognitive vulnerability in
schizophrenia; verbal processing, attention, and cognitive control
(Filbey et al., 2008; Wobrock et al., 2009). This also allows for the
analysis of aggregate cognition and the interaction between large-
scale cortical networks. Thus, the effort mode network was defined
as activation in the presence of the task, while the default mode
network was defined as activation in the absence of the task. The
relationship or anti-correlation between these networks may be of
particular interest in clinical groups such as schizophrenia (Broyd
et al., 2009; Mannell et al., 2010; Nygård et al., 2012).
The default mode network includes areas in the medial pre-
frontal and temporal lobes, including orbitofrontal cortex, the
posterior cingulate cortex, precuneus (PC), fusiform/lingual gyri,
and inferior parietal lobule (Fox and Raichle, 2007; He et al.,
2012). It has been suggested that the default mode network
reflect endogenous generated thought, e.g., inner speech and self-
referential thought (He et al., 2012). The activation of these net-
works increases during rest and non-task phases, and decreases
during periods of goal-directed tasks (Schneider et al., 2011). Sev-
eral studies have shown that patients with schizophrenia fail to
show this brain activation pattern, especially the task-induced de-
activation, as compared with healthy controls (Pomarol-Clotet
et al., 2008; Whitfield-Gabrieli et al., 2009; Mannell et al., 2010;
Schneider et al., 2011; He et al., 2012; Nygård et al., 2012). The
effort mode network, on the other hand, is assumed to involve
areas in the inferior and middle frontal gyrus, supplementary
motor area (SMA), anterior cingulate, posterior temporal cortex,
and parietal cortex (cf. Fox and Raichle, 2007; Hugdahl et al.,
2009; Nygård et al., 2012). Decreased brain activation to effort
demanding tasks have been shown repeatedly in schizophrenia
(Hugdahl et al., 2004, 2009; Karlsgodt et al., 2007; Koch et al.,
2008; Nygård et al., 2012). Following the paradigms used in the
original resting state, default mode, studies (e.g., Buckner et al.,
1996; Shulman et al., 1997; see also Binder, 2012 for reviews of
the early history of resting state studies), where a “rest” or “pas-
sive” task was used to contrast active task processing, we analyzed
the OFF-block against ON-blocks to contrast a rest, or passive,
task (OFF-blocks) with an active task (ON-blocks). In this way
we could study the ongoing interaction between task-absent and
task-present state processing activity. This was achieved simply by
comparing activation for the ON–OFF-block contrast with activa-
tion for the OFF–ON block contrast. This is not the “traditional”
way of studying the default mode network activity. However, there
are several arguments for the present procedure. In this way it
is also possible to study the switching between activation states
during task-present and task-absent conditions, and whether one
group is impaired compared to another group. The use of a pro-
longed resting period with no-task activation (as in a typical
resting state paradigm) has the disadvantage that two states are
not studied simultaneously.
The aim of the present study was therefore to examine brain
activation in patients with schizophrenia with and without a his-
tory of previous cannabis use, and to explore if previous neurocog-
nitive differences between these groups have neuronal substrates
that could be detectable in an fMRI study. We were particularly
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interested in differences in the ability to up-regulate the effort
mode network during the task-present condition.
MATERIALS AND METHODS
SUBJECTS AND CLINICAL ASSESSMENTS
Thirty-one patients with a DSM-IV (American Psychiatric Associ-
ation, 1994) and ICD-10 (WHO, 1992) diagnosis of schizophrenia
were included in the study, diagnosed by means of Structural
Clinical Interview for DSM-IV (First et al., 1995). Five of these
patients were subsequently excluded due to sporadic cannabis use
that was difficult to categorize. The remaining 26 patients were
divided into two sub-groups; a Can− group (n= 13) with no his-
tory of cannabis use and a Can+ group (n= 13) with a history
of cannabis use. There were 8/5 and 11/2 men/women in the two
groups, respectively. Clinical, cognitive, and demographic data, as
well as data on social and general functioning (Birchwood et al.,
1990), is presented in Table 1.
History of cannabis use was based on clinical records and SCID-
interviews, and was further validated through a questionnaire
specifically designed for this study. The questionnaire was filled
out twice; by the responsible clinician (psychiatrist/psychologist)
and a research psychologist. Lifetime and current illegal drug use
was recorded, including types of drugs, how often and over how
long period they had been used. The patients that reported regular
cannabis use over at least 2 years or frequent (at least weekly)
cannabis use over 6 months were included in the Can+ group.
Patients with no history of cannabis use were included in the
Can− group. Sporadic use of amphetamine, LSD, and ecstasy
Table 1 | Demographic, clinical, and cognitive data by group.
No-cannabis group (Can−) Cannabis group (Can+) P
Mean (SD) Min−Max Mean (SD) Min–Max
Age (years) 36.23 (11.00) 18–57 33.38 (10.36) 19–55 NS
Education (years) 14.04 (3.14) 10–19 11.46 (1.90) 9–15 0.02
Age of onset (years) 25.68 (6.86) 17–39 19.46 (7.00) 7–29 0.04
Duration of illness (years) 11.68 (10.95) 2–33 13.38 (10.68) 4–34 NS
Medication (DDD) 1.42 (0.84) 1–3 1.26 (0.95) 0–3 NS
PANSS
Total scores 52.83 (15.67) 34–81 49.15 (12.19) 31–75 NS
Positive subscale 11.83 (5.89) 7–22 12.54 (5.83) 7–23 NS
Negative subscale 17.25 (6.12) 10–31 13.23 (5.40) 7–26 NS
Gen. psychopath. subscale 23.75 (7.10) 16–37 23.38 (6.61) 16–40 NS
GAF function scores 44.73 (19.51) 20–80 44.00 (16.65) 28–81 NS
SOCIAL FUNCTIONING SCALE
Withdrawal 101.94 (6.70) 90.50–110.00 107.00 (8.35) 93. 50–116.50 NS
Interpersonal behavior 117.67 (17.11) 96.00–145.00 121.56 (19.89) 100.00–145.00 NS
Prosocial activities 112.39 (12.17) 92.00–124.00 102.56 (14.14) 73.50–118.50 NS
Recreation 110.33 (17.04) 80.00–133.00 112.31 (13.63) 96.00–135.00 NS
Independence-Competence 106.83 (14.49) 79.00–127.00 109.00 (10.82) 93.50–128.00 NS
Independence-Performance 113.89 (10.61) 97.50–123.00 108.13 (13.15) 95.50–123.00 NS
Employment/Occupation 106.06 (14.79) 81.50–122.50 99.44 (14.59) 81.50–122.50 NS
COGNITIVE FUNCTIONING
Verbal abilities 48.92 (5.25) 39.68–58.52 51.57 (4.87) 43.81–59.08 NS
Visuospatial abilities 41.24 (8.67) 26.64–50.82 47.25 (11.07) 22.94–58.86 NS
Learning 40.18 (8.18) 30.75–56.58 46.44 (11.81) 33.88–64.58 NS
Memory 43.41 (6.67) 35.71–54.18 48.92 (7.14) 38.86–61.66 NS
Attention/working memory 42.12 (8.34) 31.52–55.29 44.68 (6.75) 33.77–51.34 NS
Executive functioning 37.48 (15.89) 18.35–64.22 40.48 (17.51) 2.51–56.87 NS
Visuomotor speed 37.79 (5.80) 31.66–47.15 42.27 (6.40) 33.40–52.32 NS
SD, standard deviation; Age of onset, age at first psychotic experience; Duration of illness, age at testing minus age of onset; DDD, defined daily dose; PANSS,
The Positive and Negative Syndrome Scale for Schizophrenia; GAF, Global Assessment of Functioning Scale. The seven cognitive domains signify mean t-scores.
Verbal abilities=WAIS-(Wechsler Adult Intelligence Scale) III Similarities, WAIS-III Vocabulary, Controlled oral word association test Letters/animals. Visuospatial abil-
ities=WAIS-III Digit Symbol-coding, WAIS-III Block design, Rey–Osterrieth Complex Figure test Copy. Learning=The California Verbal Learning Test-II (Immediate
Recall), WAIS-Digit Span. Memory=CVLT-II (Delayed Recall), ROCF Delayed recall. Attention/working memory=WAIS-III Digit Span, Digit Vigilance test, CalCAP
Continuous Performance test (Choice Reaction Time/Sequential Reaction Time), Trail Making test B. Executive functioning=Wisconsin Card Sorting test, Stroop
color/word conflict. Visuomotor speed=Trail Making test A, WAIS-III Digit Symbol-coding, Grooved pegboard test, CalCAP Reaction time test. There were missing
data for the following variables: Education (2), Medication (7), Duration of illness (3), Age of onset (3), PANSS (1), Cognition (7), Social functioning (8), and GAF (4).
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were reported for 5, 3, and 1 of the Can+ patients, respectively.
For all Can+ patients, except one, cannabis use started before
their psychosis debut, in the age range of 11–25 years. Exclusion
criteria were clinically significant neurological disease, history of
head injury, substance abuse within the past 6 month (except two
patients who had used cannabis twice the last 6 months, but not
the last 2 months), and hearing impairment, defined as failing to
correctly perceive tones at 20 dB at 500, 1000, 2000, and 4000 Hz
or having an inter-aural difference larger than 15 dB. The Positive
and Negative Syndrome Scale (SCI-PANSS; Kay et al., 1989) was
used for symptom ratings, performed about half an hour before
the MR-scanning. All subjects were right-handed as determined by
a self-report questionnaire (Raczkowski et al., 1974). The project
was approved by the Regional Committee for Medical Research
Ethics at Western Norway Health Authority (REK-Vest).
TASK
The patients were scanned while listening through headphones
to dichotic presentations of series of consonant-vowel (CV) sylla-
bles. The syllables consisted of the six stop-consonants paired with
the vowel/a/to form six CV-syllables/ba/, /da/, /ga/, /ka/, /pa/, /ta/.
The CV-syllables were presented through MR compatible head-
phones with insulating materials that also compensated for the
ambient scanner noise. Instructions were given verbally before the
experiment and in written form via LCD goggles (NordicNeu-
roLab)1 during the MR-scanning. The patients were instructed
to report the syllable they heard best on each trial, and for 2/3
of the trials (pseudo-randomized) they were told to focus on
and report only from the right or left ear to increase the atten-
tion and executive load of the task (Hugdahl and Andersson,
1986). Which ear to focus attention on and report from was indi-
cated by an arrow in the LCD goggles in addition to the written
instructions. Further details about the paradigm are described
elsewhere (van den Noort et al., 2008). The verbal response after
each syllable pair presentation was recorded with an in-house
built air-conducting microphone that was placed on the head-
coil and attached to a digital recorder (M-audio Microtracker
24/962, or on a DAT recorder) outside the MR chamber, and
the responses were later scored. In order to focus on the cogni-
tive aspects of the dichotic listening (DL) task, we calculated an
aggregate score based on the two conditions when subjects are
explicitly instructed to focus attention on either the right or left
ear stimulus.
MR-SCANNING
MR imaging was performed with a 3.0T GE Signa HDx scanner.
Head movements were restrained by additional padding inside
the head-coil. For positioning the slices for functional imaging
parallel to the AC-PC line, a high-resolution T1-weighted 3D vol-
ume image was acquired prior to the EPI image acquisitions using
a FSPGR pulse sequence with 122 sagittal slices (64× 64 matrix
size, 1.0 mm slice thickness, TE= 30 ms, TR= 1500 ms, FA= 90).
The fMRI part involved a sparse-sampling EPI sequence proto-
col (van den Noort et al., 2008) where the EPI volumes were
1http://www.nordicneurolab.no
2http://www.m-audio.com
acquired with repetition time TR= 5.5 s, and acquisition time
TA= 1.5 s, with a silent gap of 4 s, during which the CV-syllable
stimuli were presented and the verbal responses were recorded.
The stimulus (CV-syllables) presentation started 0.6 s after the
TA, leaving approximately 2.9 s for verbal responses after each
stimulus presentation. A block design with nine ON–OFF-block
combinations was used. In total, 184 BOLD sensitive EPI volumes
were acquired with 3.44 mm× 3.44 mm× 5.5 mm voxel size and
25 axial slices covering most of the cerebrum. The first four EPI
volumes were discarded prior to the processing of the data. There
was a MR scanner upgrade about half-way into the project that was
outside of our control. This affected the sensitivity in the images.
However, there were about equally as many patients before and
after the upgrade and a Chi-square test showed that the differ-
ence in number of patients in the Can− (before upgrade 7/after
upgrade 6) and Can+ (before upgrade 8/after upgrade 5) groups
before and after the upgrade was not significant, χ2(1)= 0.161,
p= 0.691, n.s.
fMRI ANALYSIS
The MR DICOM images were converted to the ANALYZE file for-
mat using the nICE software version 2.3.63. The converted images
were pre-processed using the Statistical Parametric Mapping
(SPM8) software package (Wellcome Trust Centre for Neuroimag-
ing)4 implemented in Matlab R2009b (Mathworks Sherborn, MA,
USA)5 and then realigned and corrected for possible movement
distortions (unwarp) and normalized into the Montreal Neu-
rologic Institute (MNI) reference brain space (Ashburner and
Friston, 1999). The EPI template that is included in the SPM8 soft-
ware was used for the normalization. The normalized images were
re-sampled with an isotropic voxel size of 3 mm× 3 mm× 3 mm
and smoothed with an 8 mm full-width at half maximum Gaussian
kernel in the x, y, and z directions. The predictors were convoluted
with the hemodynamic response function (hrf) and a temporal
high pass filter (cut-off: 128 s) was applied, and with a significance
threshold of p= 0.001.
For the group analyses, the individual contrast-files were sub-
jected to t -tests. At the second-level, group analyses, the individual
contrast images for the three attention instruction conditions
were merged into an aggregated contrast image, subjected to one-
sample t -tests for main-effects for the groups together and for the
respective group separately, and to two-sample t -tests for com-
parisons between the groups. The results were explored at an
FWE corrected statistical threshold of p< 0.05 for an omnibus
analysis involving both groups together, and by an uncorrected
threshold of p< 0.001 when analyzing the groups separately and
compared with each other, due to loss of statistical power. Only
clusters with at least 10 (FEW corrected analysis) or 20 (uncor-
rected analyses) voxels were considered. Coordinates in Montreal
Neurological Institute (MNI) space were validated for anatomi-
cal localization using the Automated Anatomical Labeling (AAL;
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The task condition, when the syllables were presented, corre-
sponded to the ON-blocks condition. The no-task condition,when
no stimuli were presented, corresponded to the OFF-blocks condi-
tion. There were three different instructions (conditions) of how
to focus attention, each with a set of 30 syllables, yielding 90 sylla-
ble pair presentations. Each ON-block consisted of 10 syllable pair
presentations with a unique instruction for each ON-block, with
three repetitions of each instruction condition. Thus, there were
a total of nine ON-blocks that were alternated with nine OFF-
blocks with no stimuli presentations. Within each ON-block, the
inter-stimulus interval was 5.5 s, and the length of an ON-block
and corresponding OFF-block was 65 s. To test the ability to up-
regulate and down-regulate activation as hypothesized the change
in activation between the task-present and task-absent conditions
were examined by using contrasts comparing activation from the
ON and OFF-blocks.
In order to separate significant clusters being activated when
stimuli were presented (task condition), from clusters being acti-
vated in the absence of stimuli (no-task condition), respectively,
two different approaches to the data were used. The first approach
would correspond to setting up contrasts with images acquired
during ON-blocks minus images acquired during OFF-blocks. The
second approach would correspond to setting up contrasts with
images acquired during OFF-blocks minus images acquired dur-
ing ON-blocks. Thus, voxels activated during ON–OFF-blocks,
and OFF–ON-blocks, respectively would by definition be separate
activations, not occurring at the same time, and following differ-
ent time-courses dependent on whether a stimulus was presented
or not. Thus, the ON–OFF contrast= the average of activations
from images acquired during the ON-blocks. The OFF–ON con-
trast= the average of activations from images acquired during the
OFF-blocks.
Significant voxels being activated during the ON time-course
would broadly speaking belong to task-present, or effort mode
network (van Wageningen et al., 2009), while significant voxels
being activated during the OFF time-course would broadly speak-
ing belong to task-absent, or default mode network (Raichle et al.,
2001; Fox and Raichle, 2007). Significant clusters have been plot-
ted as coronal, sagittal, and axial slices in Figures 1–5. This means
that some clusters may not be seen in all slices. All significant clus-
ters are however specified in Table 2 as MNI coordinates for the
respective activated clusters, and in the text. All figure displays are
with neurological display convention, i.e., left is left and right is
right.
BEHAVIORAL, CLINICAL, AND DEMOGRAPHIC DATA ANALYSIS
Group differences for the clinical, cognitive, and demographic
data and averaged scores from the DL task that are reported
in Table 1 were tested by means of one-way ANOVAs and for
gender by means of Chi-square. The DL performance data were
scored and summed for right and left correct ear reports and
then averaged across the two attention instruction conditions
for each subject. Two kinds of aggregate DL scores were calcu-
lated. One involved averaging the right ear score when instructed
to focus attention to the right side and the left ear score when
instructed to pay attention to the left side. The other aggregate
FIGURE 1 | Significant activations for the main-effect of ON–OFF during
task-presence (red color), and OFF–ON during task-absence (blue
color), for both groups together. Activations were thresholded at an FEW
correction of p<0.05 and with a minimum of 10 voxels to define a cluster.
FIGURE 2 | Significant activations for the main-effect of ON–OFF
during task-presence (red color), and OFF–ON during task-absence
(blue color), for the Can− group. Activations were thresholded at
uncorrected p<0.001 and with a minimum of 20 voxels to define a cluster.
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FIGURE 3 | Significant activations for the main-effect of ON–OFF
during task-presence (red color), and OFF–ON during task-absence
(blue color), for the Can+ group. Activations were thresholded at
uncorrected p<0.001 and with a minimum of 20 voxels to define a cluster.
FIGURE 4 | Significant activations for the ON–OFF (red colors) and
OFF–ON (blue colors) contrasts when comparing the groups against
each other; Can−minus Can+. The absence of any red colored
activations indicate absence of significant activations for the ON–OFF
comparison. Activations were thresholded at uncorrected p<0.001 and
with a minimum of 20 voxels to define a cluster.
FIGURE 5 | Significant activations for the ON–OFF (red colors) and
OFF–ON (blue colors) contrasts when comparing the groups against
each other; Can+minus Can−. The absence of any blue colored
activations indicate absence of significant activations for the OFF–ON
comparison. Activations were thresholded at uncorrected p<0.001 and
with a minimum of 20 voxels to define a cluster.
was taking both the right and left ear scores together, for both
attention instruction conditions. In order to explore whether per-
centage of correct reports on the cognitive DL task was associated
with increased or decreased brain activation in key areas in the
default and effort mode networks, we correlated the fMRI BOLD
response in the combined area of SMA and anterior cingulate
cortex (ACC), and in the Precuneus (PC) area with the aggre-
gated percentage correct reports in the DL task, respectively, and
separated for the two groups. These brain regions were defined
as regions of interest (ROIs) because they are key regions in the
effort mode, and default mode networks, respectively. The ROIs
were defined anatomically from the automated anatomical label-
ing (AAL), Tzourio-Mazoyer et al., 2002) atlas for each subject,
to avoid confounding with individual activations, and the aver-
aged BOLD data were then extracted for each subject across the
time-series of image acquisitions.
RESULTS
CLINICAL, DEMOGRAPHIC DATA
There were no significant differences between the two groups for
the clinical, DL, cognitive, and demographic data, the social or gen-
eral functioning data shown in Table 1, expect for Education [F(1,
22)= 5.93 p= 0.02] and Age of onset [F(1, 22)= 4.62 p> 0.04].
The Can+ group had fewer years of education, and an earlier age
of illness onset.
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Table 2 | Anatomical localization, MNI X,Y, Z coordinates, Z -value, and corresponding figures for the different contrasts tested.
Comparison/coordinates X Y Z Z -value Corresponding figure
GROUPSTOGETHER
ON–OFF Figure 1
Right middle temporal gyrus 63 −22 −2 7.42
Left superior temporal gyrus −63 −13 4 6.95
Supplementary motor area/ 0 −1 64 6.51
Anterior cingulate cortex 1 22 29 5.89
Left inferior parietal lobule −45 −58 55 5.50
Right inferior parietal lobule 51 −55 55 5.35
Left postcentral gyrus −57 −10 43 7.08
Left middle frontal gyrus −36 44 25 4.77
Right middle frontal gyrus 36 41 28 4.53
OFF–ON
Right medial orbitofrontal cortex 0 44 −5 5.43
Left calcarine/precuneus −3 −58 16 4.50
Right occipital lobe 6 −55 16 4.50
Posterior cingulate cortex 0 −52 28 4.47
GROUPS SEPARATED; Can−
ON–OFF Figure 2
Right superior temporal gyrus 60 −19 −5
Left middle temporal gyrus −60 −22 −2
Right supplementary motor area 6 −4 64
Left inferior parietal lobule −48 −55 55
Right inferior parietal lobule 48 −55 52
OFF–ON
Right precuneus 6 −52 28
Left anterior cingulate −6 35 −2
Medial orbitofrontal cortex 0 44 −5
GROUPS SEPARATED; Can+
ON–OFF Figure 3
Right superior temporal gyrus 60 −25 1 5.52
Left middle temporal gyrus −60 −10 −5 5.48
Right supplementary motor area 6 2 64 4.99
Cerebellum 0 −40 −8 4.54
OFF–ON
Left medial orbitofrontal gyrus 0 44 −8 3.67




Right posterior cingulate cortex 3 −37 28 4.23
Right inferior parietal lobule 48 −49 43 4.17
Right occipital lobe 6 −82 43 3.75
Left cerebellum −33 −79 −35 3.74
Right precentral gyrus 51 8 37 3.68
Left superior temporal gyrus −45 −28 10 3.63
Left inferior frontal gyrus −51 32 22 3.49
Right angular gyrus 54 −64 28 3.82
Left lingual gyrus −9 −43 4 3.75
Right precuneus 6 −82 43 3.75
(Continued)
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Table 2 | Continued
Comparison/coordinates X Y Z Z -value Corresponding figure
GROUPS COMPARED; Can+MINUS Can−
ON–OFF Figure 5
Right posterior cingulate cortex 3 −34 25 3.99
Right inferior parietal lobule 48 −49 43 3.59





See Table 2 for MNI coordinates for the respective activated
clusters. A first analysis compared the main-effect of activa-
tions during task processing (ON-blocks) and during task-absence
(OFF-blocks), across the two groups.
The ON–OFF contrast showed significant clusters in the left
and right superior and middle temporal gyrus, in the SMA, and
extending into the ACC, left and right inferior parietal gyrus,
left postcentral gyrus, left and right middle frontal gyrus. Thus,
the activations seen for the ON–OFF contrast, across groups
were essentially located in the effort mode network and adjacent
areas.
The OFF–ON contrast showed significant clusters in the right
medial orbitofrontal cortex, the left PC, right PC/calcarine sul-
cus, posterior cingulate cortex. See Figure 1 and Table 2. Thus,
the activations seen for the OFF–ON contrast, across groups were
essentially located in the default mode network.
Groups separated
A second analysis compared the main-effect of activations dur-
ing task-presence (ON-blocks) and during task-absence (OFF-
blocks), separate for the two groups. For the Can− group, the
ON–OFF contrast showed significant clusters in the right supe-
rior and left middle temporal gyri, SMA, left and right inferior
parietal lobules. The corresponding OFF–ON contrast showed
significant clusters in the right PC, left ACC, and extending into
medial orbitofrontal cortex. See Figure 2 and Table 2.
For the Can+ group the ON–OFF contrast showed significant
clusters in the right superior temporal gyrus, left middle temporal
gyrus, right SMA, extending into the ACC, and the cerebellum.
The corresponding OFF–ON contrast showed significant clusters
in the right medial orbitofrontal cortex. See Figure 3 and Table 2.
Groups compared
A third analysis compared the two groups in the same analysis, sep-
arately for ON–OFF and OFF–ON contrasts. For the Can−minus
Can+ ON–OFF comparison there were no remaining significant
clusters. For the OFF–ON comparison there were significant clus-
ters in posterior cingulate cortex, left inferior frontal gyrus, right
inferior parietal lobule, right precentral gyrus, right occipital lobe,
left superior temporal lobe. See Figure 4 and Table 2.
For the as Can+ minus Can− ON–OFF comparison there
were significant clusters in the right posterior cingulate cortex,
right inferior parietal lobule, the right precentral gyrus. For the
OFF–ON comparison there were no remaining significant clusters.
See Figure 5 and Table 2.
DL performance data and correlations with BOLD data
The mean correct reports for the DL aggregate score based on
the single right and left ear score for the attend-right and attend-
left instruction, respectively, were; 34.35% (8.83) and 43.20 (8.93)
for the Can− and Can+ groups, respectively. An ANOVA showed
the mean difference to be significant, F(1, 24)= 6.44, p= 0.018.
However, taking also the overall percentage correct reports into
consideration, i.e., including also the correct reports from the
non-attended ear, the significance disappeared, F(1, 24)= 2.16,
p= 0.154, n.s. The means for the overall aggregate scores were;
34.55 (6.79) and 38.39 (6.53) for the Can− and Can+ groups,
respectively. There were no significant correlations for the selected
BOLD ROIs and DL mean scores, neither for the Can−, nor for
the Can+ group, or for the single or overall DL aggregate scores.
DISCUSSION
Although the Can− and Can+ group showed substantial similari-
ties across activation patterns, there were also group differences in
activation and performance, suggesting a difference in neuronal
dynamics between the groups. The Can− and the Can+ group
showed overlapping activations in the ACC in both conditions,
in addition to the expected patterns for the default and effort
mode networks. The groups differed, however, in that the inten-
sity and extension of the activations were more pronounced for
the task-present condition in the Can+ group, while it was more
pronounced for the task-absent condition in the Can− group (see
Figures 2 and 3). These overall differences were further substan-
tiated in the direct comparison between the groups. The Can−
group showed no remaining activations in the task-present con-
dition above and beyond what was seen in the Can+ group. For
the task-absent condition the Can− group showed activation in
the posterior cingulate, PC, inferior parietal lobule, middle tem-
poral gyrus, occipital lobe, which are areas located in the default
mode network, while the Can+ group did not show any remain-
ing activation in this condition (see Figures 4 and 5). Thus, the
Can+ group showed increased activation in the task-present con-
dition and decreased activation in the default mode network in
the absence of the task as compared to the Can− group.
These cortical responses were, to some extent corroborated
in the behavioral data, when comparing the groups on single
DL aggregate score, although this significance disappeared for
the overall aggregate score. There were moreover no significant
Frontiers in Psychiatry | Schizophrenia October 2012 | Volume 3 | Article 94 | 8
Løberg et al. Cannabis, schizophrenia, and brain functioning
correlations with the BOLD activation in the selected SMA/ACC
and PC ROIs. Thus, although there were some indications of a dif-
ference in cortical dynamics and cognitive performance between
the groups, in favor of the Can+ groups, it is difficult to draw any
firm conclusions from this since the correlations with performance
on the cognitive task were not significant. Possibly the fMRI par-
adigm may detect more subtle group differences than the DL test,
in particular for small sample sizes. The limited sample size may
be too small to detect differences in DL performance. This is con-
sistent with that the cannabis users showed superior performance
on all cognitive domains, but it did not reach significance.
The Can+ group up-regulated the effort mode network dur-
ing the task-present condition and down-regulated the default
mode network during the task-absent condition to a larger extent
than the Can− group. This is consistent with other studies show-
ing aberrant activation patterns in schizophrenia patient groups
in general. In line with this, both decreased brain activation to
effort demanding tasks and increased resting state brain activa-
tion have been shown in schizophrenia (Hugdahl et al., 2004;
Karlsgodt et al., 2007; Broyd et al., 2009; Whitfield-Gabrieli et al.,
2009). Moreover, it has been proposed that hyper-activation
of the default brain network during task processing may con-
tribute to thought disturbances and auditory hallucinations in
schizophrenia (Whitfield-Gabrieli et al., 2009; Northoff and Qin,
2011). Even though there was some overlap between the patient
groups, the Can− group did show a pattern closer to the typical
schizophrenia findings, probably indicating more impaired brain
functioning.
The BOLD group differences could not be explained by dif-
ferences in clinical variables. The Can+ group had fewer years of
education and earlier age of onset, representing a disadvantage for
the Can+ group. The fewer years of education is a paradox, how-
ever, since it seemingly suggests worse cognitive functioning, and
this is not reflected in the behavioral data by the DL test. Alter-
natively, it can be attributed to the negative effects of drug use
on school performance. It can also be argued that results reflect
better social and organizational skills necessary to buy cannabis.
This would be consistent with the cannabis users being a better
functioning subgroup. But, it seems unlikely that this explanation
of the findings, since it does not explain cannabis as a risk factor
for schizophrenia and the earlier onset age in the cannabis users.
Furthermore, some clinical data from the present study, although
limited by small sample size, suggests that the groups did not
differ in social functioning. The cannabis users showed better per-
formance on all cognitive domains, however, it should be noted
that these differences were not significant. The interpretation and
generalizability of the present findings is limited by the small sam-
ple, and effects of previous use of other illegal drugs cannot be
ruled out. The present sample did not include meth-amphetamine,
cocaine, or opiate abusers, and for those that did report use of other
drugs, cannabis had nevertheless been the main drug of choice.
The present fMRI activation results are consistent with previous
neuropsychological findings with regard to cognition (Løberg and
Hugdahl, 2009). Since THC causes adverse cognitive short-term
effects in vulnerable individuals (D’Souza et al., 2005), cannabis
may cause a transient cognitive breakdown enabling a psychotic
outbreak, but without the typical long-lasting neurocognitive vul-
nerability. These changes may be more biochemical in nature,
influencing the reactivity of the cannabinoid receptor systems via
the cannabinoid receptor 1 (CNR1; DeLisi, 2008; Ho et al., 2011).
This receptor system is widely expressed in the brain, especially
in areas relevant to schizophrenia (Ho et al., 2011). Furthermore,
the developing adolescent brain may be particularly sensitive for
these effects (Ho et al., 2011). The notion of a transient change
of brain functioning is also supported by findings of fewer neu-
rological soft signs in schizophrenia with cannabis use (Bersani
et al., 2002; Stirling et al., 2005; Ruiz-Veguilla et al., 2009). Fur-
thermore, a different illness pathway to schizophrenia is supported
by the present findings in the sense that most of the patients
started using cannabis before their psychotic debut, in addition
to the earlier age of onset in the Can+, which also replicate pre-
vious studies (Stirling et al., 2005; Barnes et al., 2006; Large et al.,
2011). Taken together, although there were similarities in behav-
ioral responses, there were also differences between the groups
in the dynamics of cortical responding, in particular up- and
down-regulation of task-present and task-absent-related cortical
networks. Future studies should aim at unraveling the exact nature
of these differences.
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